Evidence-based emergency medicine/systematic review abstract. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness.
Pitts
Stephen R
SR
Department of Emergency Medicine Emory University School of Medicine, Atlanta, GA 30303, USA. pitts@sph.emory.edu
D000293:Adolescent; D000328:Adult; D006801:Humans; D008875:Middle Aged; D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000367:Age Factors; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016001:Confidence Intervals; D004635:Emergency Medicine; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006146:Guanidines; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir; D011714:Pyrans; D016032:Randomized Controlled Trials as Topic; D012794:Sialic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D053243:Zanamivir; D000078202:Systematic Reviews as Topic
D000081:Acetamides; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D009439:Neuraminidase; D053139:Oseltamivir; D011714:Pyrans; D012794:Sialic Acids; D053243:Zanamivir